European Medicines Agency

Surge in demand this winter puts pressure on supplies amid sharp disagreement over long-term impact of pricing

Government urged to secure supply of the breakthrough treatment as soon as possible

Adapted boosters to be available within days following recommendation by EMA

Separate shots developed by rivals Moderna and Pfizer-BioNTech are now set for EC approval

Authorisation in European Union for Omicron-specific vaccines expected next month

Depending on your age group and level of vulnerability, you may be set for a jab in autumn as infection threats intensify

ECDC and EMA say there is ‘no clear evidence’ to support wider second booster campaign

Amryt Pharma has delivered first ever therapy for patients suffering from EB, or butterfly skin disease

Valneva relies on traditional vaccine technology used in some shots against polio and hepatitis

State spent 13.4% of €19bn budget on medicine, pharmacies and wholesaling in 2021

Delays in reimbursing new treatments may affect course of illnesses, study says

EMA has 67 days to decide whether to back recommendation of its expert committee

Recommendation comes as global cases of virus top 500m amid Omicron surge

North is granted a derogation in bid to resolve ‘main issue’ with NI protocol

Another 7,005 Covid cases reported in State as Niac approves extra booster for over-65s

Delta variant which was dominant late last year is no longer found here

Moderna applies for emergency use authorisation in the US for a second booster for adults

Ireland now holds both the chair and director-general roles at EU’s drug regulator

Another 11,671 PCR-confirmed coronavirus cases reported in past few days

HSE urges parents with concerns to turn to ‘trusted sources’ for information

European Medicines Agency says no evidence to suggest vaccines affect fertility

Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications

Paxlovid could help people avoid serious illness and hospitalisation, says drug regulator

Companies to test fourth dose of current vaccine against fourth dose of new one

Most are mild to moderate and many had resolved or were resolving when reported

Among issues being addressed are what defences to have ready, says Minister for Health

State’s vaccine advisers have been asked for view on second booster for older people

Cost of deal is three times annual budget usually in place for new drugs in Republic

Parents can register children aged five to 11 who have a health condition

Other vaccine producers also studying potential for adapted formulations

Validity will be extended after booster shot without a time limit

System first introduced for vaccine distribution largely seen as fair by member states

Manufacturers of mRNA vaccines can tweak them to cope with virus mutations, says Martin

The State is in a race between the booster and the Omicron Covid-19 variant

The HSE is currently finalising a plan for the vaccination of children aged five to 11

Recent rise in cases has been accompanied by a much smaller increase in admissions to ICU

Vaccinating children against Covid-19 protects them now, into adulthood and beyond

Covid-19 cases rising among 5-11 age group but severe illness still ‘rare’, says report

Europe Letter: Disinformation on social media fuels vaccine sceptic movement

Von der Leyen comments as signs Germany to join Austria in move towards obligatory jabs